Can the intake of antiparasitic secondary metabolites explain the low prevalence of hemoparasites among wild Psittaciformes?

dc.contributor.authorJuan F. Masello
dc.contributor.authorJavier Martı́nez
dc.contributor.authorLuciano Calderón
dc.contributor.authorMichaël Wink
dc.contributor.authorPetra Quillfeldt
dc.contributor.authorVirginia Sanz
dc.contributor.authorJörn Theuerkauf
dc.contributor.authorLuis Ortiz–Catedral
dc.contributor.authorIgor Berkunsky
dc.contributor.authorDianne H. Brunton
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T14:13:00Z
dc.date.available2026-03-22T14:13:00Z
dc.date.issued2018
dc.descriptionCitaciones: 29
dc.identifier.doi10.1186/s13071-018-2940-3
dc.identifier.urihttps://doi.org/10.1186/s13071-018-2940-3
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/45217
dc.language.isoen
dc.publisherBioMed Central
dc.relation.ispartofParasites & Vectors
dc.sourceJustus-Liebig-Universität Gießen
dc.subjectBiology
dc.subjectPsittaciformes
dc.subjectAntiparasitic agent
dc.subjectParasitology
dc.subjectPhysiology
dc.subjectAntiparasitic
dc.subjectPharmacology
dc.titleCan the intake of antiparasitic secondary metabolites explain the low prevalence of hemoparasites among wild Psittaciformes?
dc.typearticle

Files